Framingham, Massachusetts — According to state and local economic development sources CRISPR Therapeutics plans to build out new space in Framingham. The company plans to occupy the new space in Framingham, on or about March 1, 2021. According to the company website CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. Our multi-disciplinary team of world-class researchers and drug developers is working to translate this technology into breakthrough human therapeutics in a number of serious diseases.

To learn more about CRISPR Therapeutics, visit http://www.crisprtx.com/

Company Contact:
Samarth Kulkarni, Chief Executive Officer
https://www.linkedin.com/in/samarthkulkarni/
617-315-4600

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved